The US Food and Drug Administration (FDA) has granted regulatory approval to Medicrea group's PASS LP system for the treatment of adolescent idiopathic scoliosis.
The system, which the company claims to be the lowest profile pedicle screw spinal fusion system available on the market, uses the company's proprietary derotation connectors and technique to correct the deformity in all planes.
The France-based company said derotation in the coronal plane is obtained with no risk of screw ploughing or pull out while preserving sagittal balance, essential in the treatment of adolescent idiopathic scoliosis.
Medicrea president and CEO Denys Sournac said the company has provided surgeons who treat complex spinal deformities with PASS LP technology.
" We are extremely pleased to announce the approval for this new indication," Sournac added.
